We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
“Healthcare providers can use this personalized risk information to make more informed decisions about the use of oral opioids for acute pain when developing pain management plans for their patients,” SOLVD said. Read More
“The ability to test saliva samples for the presence of SARS-CoV-2 … simplifies the sample collection process and streamlines the testing workflow, while reducing the exposure of medical personnel to potentially infected individuals,” the company said. Read More
“With just one swab or sample, combination tests that are authorized for use with home-collected samples can be used to get answers to Americans faster, in the comfort and relative safety of their home, which allows patients to continue to quarantine while awaiting results,” said FDA Commissioner Stephen Hahn. Read More
The clearance allows the device to be used for monitoring quarantined patients, enabling the distanced monitoring of contagious COVID-19 patients. Read More
BAROSTIM received premarket approval from the FDA in 2019 for reducing symptoms associated with heart failure in patients who suffer from a left ventricular ejection fraction of 35 percent or less. Read More